BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 17243100)

  • 1. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
    Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
    Seya T; Matsumoto M; Ebihara T; Oshiumi H
    Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
    Hardy MP; McGGettrick AF; O'Neill LA
    Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
    Park SJ; Lee AN; Youn HS
    Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Ahn SI; Lee BY
    Int Immunopharmacol; 2009 Jan; 9(1):108-12. PubMed ID: 19000789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
    Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
    Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
    Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
    Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
    Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells.
    Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH
    Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
    Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
    Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.